Medical Device Regulation Addressing nanomaterials

Join us on December 14, 2020 for contactpointnano.ch‘s second webinar and learn about how to navigate new regulations for medical devices and new requirements regarding nanomaterials.

Time: 13.00 – 14.00
Register here

Program

13:00 – 13:10
Welcome on behalf of contactpointnano.ch (CPN)
Dr. Peter Wick (CPN)

13:10 – 13:40
Nanomaterials in Medical Devices under the Medical Device Regulation
Dr. Blanca Suarez-Merino (TEMAS Solutions)

13:40 – 14:00
General discussion and Q&A

Attendance is free.Language: English. 
We are looking forward to your participation!

Related articles

The need for awareness an... Published in Nature Nanotechnology by the group of Alke Petri-Fink and Barbara Rothen-Rutishauer (www.nature.com/articles/s41565-023-01331-4). The authors discuss the safety concerns on handling and disposing nanomaterials, the possible
Country-scale calculation... Plastic particles less than five millimeters in size, also known as microplastics, often settle far away from their point of origin. Empa researchers have now developed a
Microplastics and Nanopla... Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Safe-by-design and EU fun... Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
Crucial results for coron... Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
Nanomedicine: The Minuten... Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
NanoGVA Symposium The 2nd NanoGVA Symposium “Creating the Invisible: the development of nanomedicines” will be hosted by the University of Geneva on October 5-6, 2023. The symposium will deal
Guidelines: Safe-by-desig... A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises
Publications on Synthetic... Action plan Synthetic Nanomaterials Final report 2 September 2020 (only available in German and French) Opportunities and Risks of Nanomaterials Journal of Nanobiotechnology, 2017 Opportunities and Risks
Clinam Summit in Basel This year, the 14th European and Global Summit for Clinical Nanomedicine (CLINAM Summit) organized by the European Foundation for Clinical Nanomedicine will take place on 8-11 October